Shinya Sato, Tadashi Namisaki, Koji Murata, Yuki Fujimoto, Soichi Takeda, Masahide Enomoto, Akihiko Shibamoto, Koji Ishida, Hiroyuki Ogawa, Hirotetsu Takagi, Yuki Tsuji, Daisuke Kaya, Yukihisa Fujinaga, Masanori Furukawa, Takashi Inoue, Yasuhiko Sawada, Norihisa Nishimura, Koh Kitagawa, Takahiro Ozutsumi, Hiroaki Takaya, Kosuke Kaji, Naotaka Shimozato, Hideto Kawaratani, Kei Moriya, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji
We aimed to prospectively identify the risk factors of sarcopenia in patients with cirrhosis.Patients (n = 193) included in a discovery cohort (January 2011 and December 2014) were categorized into alcoholic (A1; n = 55) and non-alcoholic cirrhosis (NA; n = 138) groups, and those (n = 235) in a validation cohort (January 2015 to December 2019) were categorized into alcoholic (n = 92), non-alcoholic steatohepatitis-related (n = 27), and hepatitis C virus-related cirrhosis groups (n = 116)...
September 10, 2021: Medicine (Baltimore)